EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway

Wangxia Tong, Na Qin, Tao Lu, Li Liu, Rong Liu, Jibing Chen, Ning Luo iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0302766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Wangxia Tong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Project with Chinese Medicine Characteristics and Advantages, Ruikang Hospital, 2023, Nature Science Foundation of Guangxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a novel genetic biomarker, the potential role of SH3D21 in hepatocellular carcinoma remains unclear. Here, we decipher the expression and function of SH3D21 in human hepatocellular carcinoma. The expression level and clinical significance of SH3D21 in hepatocellular carcinoma patients, the relationship between SH3D21 and the features of tumor microenvironment (TME) and role of SH3D21 in promoting hepatocellular carcinoma progression were analyzed based on the bulk samples obtained from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) databases. Single-cell sequencing samples from Gene Expression Omnibus (GEO) database were employed to verify the prediction mechanism. Additionally, different biological effects of SH3D21 on hepatocellular carcinoma cells were investigated by qRT-PCR, CCK-8 assay, colony forming assay and Western blot analysis. Bioinformatics analysis and in vitro experiments revealed that the expression level of SH3D21 was up-regulated in hepatocellular carcinoma and correlated with the poor prognosis in hepatocellular carcinoma patients. SH3D21 effectively promoted the proliferation, invasion, and migration as well as the formation of immunosuppressive microenvironment of hepatocellular carcinoma. In addition, SH3D21 can activate the PI3K/AKT/mTOR signaling pathway. SH3D21 stimulates the progression of hepatocellular carcinoma by activating the PI3K/AKT/mTOR signaling pathway, and SH3D21 can serve as a prognostic biomarker and therapeutic target for hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesAdaptor Proteins, Signal TransducingHumansSignal TransductionDisease ProgressionGene Expression Regulation, NeoplasticCell ProliferationCell Line, TumorTumor MicroenvironmentSingle-Cell AnalysisSequence Analysis, RNAPrognosisCell MovementMaleFemaleBiomarkers, Tumor

Substanzen

Proto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesMTOR protein, humanAdaptor Proteins, Signal TransducingBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Hepatology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
  • The Graduate School of Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
  • Department of hepatobiliary surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
  • Centre for Translational Medical Research in Integrative Chinese and Western Medicine, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.
  • Department of Neurology, RuiKang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, Guangxi, China.

ORCID-Profile: Ning Luo

Förderung

  • National Natural Science Foundation of China
  • Key Project with Chinese Medicine Characteristics and Advantages, Ruikang Hospital, 2023
  • Nature Science Foundation of Guangxi

Zitieren

APA

Tong, W., Qin, N., Lu, T., Liu, L., Liu, R., Chen, J., & Luo, N. (2025). Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0302766

Vancouver

Tong W, Qin N, Lu T, Liu L, Liu R, Chen J, et al. Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway. PLOS ONE. 2025. doi:10.1371/journal.pone.0302766

BibTeX
@article{Tong2025,
  author = {Tong, Wangxia and Qin, Na and Lu, Tao and Liu, Li and Liu, Rong and Chen, Jibing and Luo, Ning},
  title = {Integrating bulk and single-cell RNA sequencing reveals SH3D21 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0302766}
}
Kostenlos starten →